Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC) Meeting Abstract
| Authors: | Brose, M. S.; Robinson, B.; Wirth, L. J.; Capdevila, J.; Wadsley, J.; Sherman, E. J.; Tahara, M.; Hoff, A.; Hu, M. I. N.; Gao, M.; Vaisman, F.; Churchill, C.; Lin, B. K.; Maeda, P. H.; Gilligan, A. M.; Lin, Y.; Payakachat, N.; Hadoux, J.; Elisei, R. |
| Abstract Title: | Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402582 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.11111 |
| Notes: | Meeting Abstrac: 11111 -- Source: Wos |
